9768 related articles for article (PubMed ID: 10462753)
1. The oncostatin M signalling pathway: reversing the neoplastic phenotype?
Grant SL; Begley CG
Mol Med Today; 1999 Sep; 5(9):406-12. PubMed ID: 10462753
[TBL] [Abstract][Full Text] [Related]
2. Formation of autocrine loops in human cerebral meningioma tissue by leukemia inhibitor factor, interleukin-6, and oncostatin M: inhibition of meningioma cell growth in vitro by recombinant oncostatin M.
Schrell UM; Koch HU; Marschalek R; Schrauzer T; Anders M; Adams E; Fahlbusch R
J Neurosurg; 1998 Mar; 88(3):541-8. PubMed ID: 9488310
[TBL] [Abstract][Full Text] [Related]
3. Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells.
Godoy-Tundidor S; Hobisch A; Pfeil K; Bartsch G; Culig Z
Clin Cancer Res; 2002 Jul; 8(7):2356-61. PubMed ID: 12114440
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M induces the differentiation of breast cancer cells.
Douglas AM; Grant SL; Goss GA; Clouston DR; Sutherland RL; Begley CG
Int J Cancer; 1998 Jan; 75(1):64-73. PubMed ID: 9426692
[TBL] [Abstract][Full Text] [Related]
5. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
[TBL] [Abstract][Full Text] [Related]
6. Effects of oncostatin M and tamoxifen on human melanoma cells.
Gibbs P; Chen Q; Robinson WA
Melanoma Res; 1998 Jun; 8(3):221-6. PubMed ID: 9664143
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M regulates eotaxin expression in fibroblasts and eosinophilic inflammation in C57BL/6 mice.
Langdon C; Kerr C; Tong L; Richards CD
J Immunol; 2003 Jan; 170(1):548-55. PubMed ID: 12496442
[TBL] [Abstract][Full Text] [Related]
8. Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions.
Lu C; Rak JW; Kobayashi H; Kerbel RS
Cancer Res; 1993 Jun; 53(12):2708-11. PubMed ID: 8504408
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of growth and induction of differentiation of glioma cell lines by oncostatin M (OSM).
Halfter H; Lotfi R; Westermann R; Young P; Ringelstein EB; Stögbauer FT
Growth Factors; 1998; 15(2):135-47. PubMed ID: 9505169
[TBL] [Abstract][Full Text] [Related]
10. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
[TBL] [Abstract][Full Text] [Related]
11. Complete inhibition of in vivo glioma growth by oncostatin M.
Friedrich M; Höss N; Stögbauer F; Senner V; Paulus W; Ringelstein EB; Halfter H
J Neurochem; 2001 Mar; 76(5):1589-92. PubMed ID: 11238743
[TBL] [Abstract][Full Text] [Related]
12. Oncostatin M: a new potent inhibitor of iodine metabolism inhibits thyroid peroxidase gene expression but not DNA synthesis in porcine thyroid cells in culture.
Isozaki O; Tsushima T; Miyakawa M; Emoto N; Demura H; Arai M; Sato-Nozoe Y
Thyroid; 1997 Feb; 7(1):71-7. PubMed ID: 9086575
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 and oncostatin M stimulation of proliferation of prostate cancer 22Rv1 cells through the signaling pathways of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase.
Godoy-Tundidor S; Cavarretta IT; Fuchs D; Fiechtl M; Steiner H; Friedbichler K; Bartsch G; Hobisch A; Culig Z
Prostate; 2005 Jul; 64(2):209-16. PubMed ID: 15712220
[TBL] [Abstract][Full Text] [Related]
14. Oncostatin M, a multifunctional cytokine.
Tanaka M; Miyajima A
Rev Physiol Biochem Pharmacol; 2003; 149():39-52. PubMed ID: 12811586
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.
West NR; Murray JI; Watson PH
Oncogene; 2014 Mar; 33(12):1485-94. PubMed ID: 23584474
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M: a pleiotropic cytokine in the central nervous system.
Chen SH; Benveniste EN
Cytokine Growth Factor Rev; 2004 Oct; 15(5):379-91. PubMed ID: 15450253
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1beta, tumor necrosis factor-alpha, and bacterial lipopolysaccharide.
Repovic P; Mi K; Benveniste EN
Glia; 2003 Jun; 42(4):433-46. PubMed ID: 12730964
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
[TBL] [Abstract][Full Text] [Related]
19. Oncostatin M stimulates proliferation, induces collagen production and inhibits apoptosis of human lung fibroblasts.
Scaffidi AK; Mutsaers SE; Moodley YP; McAnulty RJ; Laurent GJ; Thompson PJ; Knight DA
Br J Pharmacol; 2002 Jul; 136(5):793-801. PubMed ID: 12086989
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M: signal transduction and biological activity.
Gómez-Lechón MJ
Life Sci; 1999; 65(20):2019-30. PubMed ID: 10579456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
